Desmopressin Acetate Nasal Spray 10 mcg/0 — Class I drug recall D-1505-2020

Terminated recall by Ferring Pharmaceuticals Inc, reported 2020-08-26, distributed nationwide. Superpotent Drug

Recall number	`D-1505-2020`
Product type	Drug
Classification	Class I
Status	Terminated
Voluntary or mandated	Voluntary
Recalling firm	Ferring Pharmaceuticals Inc, Parsippany, NJ, United States
Recall initiated	2020-07-21
Classified	2020-08-17
Reported by FDA	2020-08-26
Terminated	2023-10-13
Distributed	Nationwide (US)
Quantity	184,325 nasal
Reason classes	potency
NDC	`69918-0501-05`
Lot numbers	`2020`, `2021`, `2022`, `N14695P`, `N14695S`, `N15627G`, `N15627GA`, `P10422A`, `P10422AA`, `P10430G`, `P11319M`, `P12969H`, `P12969IR`, `P13216G`, `P13216P`, `R11842A`, `R11842S`, `R12630A`, `R13071H`

Product

Desmopressin Acetate Nasal Spray 10 mcg/0.1 mL, 5mL glass vial with spray cap, Rx only, Manufactured for: AMRING PHARMACEUTICALS INC., Berwyn, PA 19312, NDC 69918-501-05

Reason for recall

Superpotent Drug

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1505-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.